← FDA DRUG APPROVALS

FDA ANDA · ANDA060004

V-CILLIN K

Sponsor: LILLY

APPLICATION
ANDA060004
TYPE
ANDA
ORIGINAL APPROVAL
1967-04-07
LATEST ACTION
1994-03-14
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

V-CILLIN KDiscontinued
PENICILLIN V POTASSIUM EQ 125MG BASE/5ML · FOR SOLUTION · ORAL
V-CILLIN KDiscontinued
PENICILLIN V POTASSIUM EQ 250MG BASE/5ML · FOR SOLUTION · ORAL

Approval history

1994-03-14Labeling · Supplement 13AP
1993-09-23Labeling · Supplement 11AP
1967-04-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →